Teradyne, Inc. (TER)

On our desk, Teradyne has turned into a classic battleground between structural AI believers and cyclical skeptics. Management explicitly stated that over 70% of Q1 revenue is AI-driven, which makes it hard to dismiss this simply as a peak-cycle story. However, the market severely punished the stock following the sequential Q2 pullback in guidance from record Q1 levels. At roughly 58x forward earnings, the valuation leaves zero room for execution errors, even if the long-term TAM expansion toward $6 billion remains intact.

Watching the tape, the volatility around earnings is staggering—witnessing drops of nearly 20% in late April and over 23% between late June and early July despite strong beats. From a risk perspective, our primary concern is working capital absorption. The immense demand surge is tying up substantial cash in receivables, inventory, and prepaid expenses as they scale. If hyperscaler capital expenditure compresses faster than anticipated, this high revenue concentration creates severe downside vulnerability.

As a quant analyst reviewing the fundamental models, the thesis relies heavily on the upcoming H1 2026 merchant GPU qualifications translating into production revenue by the second half of the year. Consensus is calling for full-year EPS of roughly $7.20 and revenue near $4.53 billion, representing over 40% top-line growth. When evaluating the entry points, traders must weigh whether the Q2 sequential step-down in revenue to a $1.15B–$1.25B range represents a temporary air pocket or a sustained deceleration in automated test equipment demand.